TRIPLE-NEGATIVE breast cancer (TNBC) remains one of the most aggressive subtypes of breast cancer, with limited targeted ...

For centuries, the European honeybee has given people honey, wax, propolis, and even venom. Now, scientists are looking ...

The Pennsylvania Act 1 of 2023 eligibility criteria for supplemental screenings based on breast density and lifetime risk of ...

The OVATION-3 trial is designed to provide an early readout in HRD and BRCA1/2-mutated ovarian cancer patients, ideally leading to rapid filing and approval.

DelveInsight's Triple-Negative Breast Cancer Market Insights report includes a comprehensive understanding of current ...

The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved diagnostics ...

Sound more like science fiction than actual science? Then, brace yourself because there are, at least, 15 breast cancer vaccine clinical trials in various stages in the U.S., some in phase II and III.

In an emotional whirlwind across three years, Hannah Curran found love, faced a cancer diagnosis, and married her soulmate on ...

No one wants to hear the words: "You have cancer." But about 1 in 8 American women will learn they have breast cancer, according to the Centers for Disease Control and Prevention. "Breast ...

While the incidence of breast cancer is highest for white women, Black women are more likely to have early-onset or more ...

New research is showing promise that a vaccine may be able to fight one type of the most common cancers in women. Phase one ...

Innovative research explores targeted therapies for early triple-negative breast cancer, aiming to reduce toxicity while enhancing treatment efficacy.